Summit Therapeutics, Inc. (SMMT)
17.30
+0.28
(+1.65%)
USD |
NASDAQ |
Dec 10, 13:12
Summit Therapeutics Total Assets (Quarterly): 261.73M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| CVS Health Corp. | 255.33B |
| UnitedHealth Group, Inc. | 315.27B |
| Iovance Biotherapeutics, Inc. | 904.95M |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.47M |
| Shareholders Equity (Quarterly) | 192.26M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |